Nuvectis Pharma, Inc.

Ownership Transactions Reported by 9 Insiders

Symbol
NVCT on Nasdaq
Location
1 Bridge Plaza, Suite 275, Fort Lee, NJ

Insiders trading volume in the past year

Nuvectis Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Charles Mosseri 10%+ Owner $24.7M +$2.24M +9.96% Jun 20, 2025
Ron Bentsur Chairman & CEO, Director, 10%+ Owner $16.4M +$119K +0.73% Jan 2, 2025
Enrique Poradosu Chief Science & Business Off $7.7M +$9.98K +0.13% Jan 2, 2025
Shay Shemesh Chief Dev. & Ops. Officer $7.64M Jan 2, 2025
Kenneth Hoberman Director $1.12M Jun 12, 2025
Matthew Kaplan Director $959K Jun 12, 2025
James F. Oliviero III Director $740K Jun 12, 2025
Michael Carson Vice President, Finance $646K -$22.5K -3.36% Jan 2, 2025
Uri Ben-Or Int. Principal Financial Off. $283K Feb 8, 2022

Recent Insider Transactions by Companies or Individuals for Nuvectis Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.